# EDGAR Filing Document

**Accession Number:** 0000277135
**File Stem:** 0000277135-26-000025
**Filing Date:** 2026-3
**Character Count:** 12844
**Document Hash:** 5255c04816b56ca943d667c9042e605e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000277135-26-000025.hdr.sgml**: 20260325

**ACCESSION NUMBER**: 0000277135-26-000025

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260324

**FILED AS OF DATE**: 20260325

**DATE AS OF CHANGE**: 20260325

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Merriwether Deidra C
- **CENTRAL INDEX KEY:** 0001757570

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05684
- **FILM NUMBER:** 26793502

**MAIL ADDRESS:**
- **STREET 1:** 100 GRAINGER PARKWAY
- **CITY:** LAKE FOREST
- **STATE:** IL
- **ZIP:** 60045
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** W.W. GRAINGER, INC.
- **CENTRAL INDEX KEY:** 0000277135
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DURABLE GOODS [5000]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 361150280
- **STATE OF INCORPORATION:** IL
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 100 GRAINGER PARKWAY
- **CITY:** LAKE FOREST
- **STATE:** IL
- **ZIP:** 60045-5201
- **BUSINESS PHONE:** 847-535-1000

**MAIL ADDRESS:**
- **STREET 1:** 100 GRAINGER PARKWAY
- **CITY:** LAKE FOREST
- **STATE:** IL
- **ZIP:** 60045

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRAINGER W W INC
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and
appoints each of Nancy L. Berardinelli-Krantz, Paul Stanukinas, and
Cherita Thomas, signing singly, the undersigned's true and lawful
attorney-in-fact to:

(1)	execute for and on behalf of the undersigned a Form ID
(including amendments thereto), or any other forms prescribed by the
Securities and Exchange Commission, that may be necessary to obtain
codes and passwords enabling the undersigned to make electronic
filings with the Securities and Exchange Commission of the forms
referenced in clause (2)below;

(2)	execute for and on behalf of the undersigned Forms 3, 4, 5,
and 144 relating to equity securities of W.W. Grainger, Inc. (the Company)
in accordance with Section 16(a) of the Securities Exchange Act of 1934
and the rules thereunder and Rule 144 under the Securities Act of 1933;

(3)	do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete any such
Form 3, 4, 5, or 144 and timely file the same with the United States
Securities and Exchange Commission and any stock exchange or similar
authority; and

(4)	take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of the attorney-in-fact, may
be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by the
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as the attorney-in-fact may approve in his or her discretion.

The undersigned hereby grants to each attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and
purposes as the attorney-in-fact might or could do if personally
present, with full power of substitution or revocation, hereby ratifying
and confirming all that the attorney-in-fact, or his or her substitute
or substitutes, shall lawfully do or cause to be done by virtue of this
Power of Attorney and the rights and powers herein granted.

The undersigned acknowledges that the attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities
to comply with Section 16 of the Securities Exchange Act of 1934
or Rule 144 under the Securities Act of 1933.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, 5, and 144 with
respect to the undersigned's holdings of and transactions in equity
securities of the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of December 10, 2025, and revokes any previously
adopted power of attorney with respect to the rights and powers
herein granted.

/s/ Deidra C. Merriwether
_______________________
Deidra C. Merriwether

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Merriwether Deidra C<br><sub>(Last) (First) (Middle)</sub><br>100 GRAINGER PARKWAY<br><sub>(Street)</sub><br>LAKE FOREST, IL 60045<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-24 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Sr. VP & CFO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>W.W. GRAINGER, INC. [ GWW ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-03-24 |  | M<sup>(1)</sup> |  | 2339 | A | $311.26 | 12574 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 40 | D | 1044.842<sup>(2)</sup> | 12534 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 160 | D | 1048.015<sup>(3)</sup> | 12374 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 80 | D | 1050.78<sup>(4)</sup> | 12294 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 200 | D | 1060.375<sup>(5)</sup> | 12094 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 349 | D | 1064.0563<sup>(6)</sup> | 11745 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 150 | D | 1064.5658<sup>(7)</sup> | 11595 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 354 | D | 1066.6927<sup>(8)</sup> | 11241 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 195 | D | 1067.9518<sup>(9)</sup> | 11046 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 331 | D | 1068.7939<sup>(10)</sup> | 10715 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 240 | D | 1070.1833<sup>(11)</sup> | 10475 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 120 | D | 1071.3167<sup>(12)</sup> | 10355 | D |  |
| Common Stock | 2026-03-24 |  | S<sup>(1)</sup> |  | 120 | D | 1072.5567<sup>(13)</sup> | 10235 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option | $311.26 | 2026-03-24 |  | M<sup>(1)</sup> |  |  | 2339 | 2022-04-01<sup>(14)</sup> | 2029-03-31 | Common Stock | 2339 | $0 | 0 | D |  |

---

### Footnotes:

(1) Transaction pursuant to a Rule 10b5-1 trading program adopted on December 23, 2025.

(2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,044.54 to $1,044.99, inclusive. The reporting person undertakes to provide W.W. Grainger, Inc., any security holder of W.W. Grainger, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (13).

(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,047.54 to $1,048.49, inclusive.

(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,050.78 to $1,050.78, inclusive.

(5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,059.84 to $1,060.70, inclusive.

(6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,063.37 to $1,064.35, inclusive.

(7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,064.41 to $1,064.77, inclusive.

(8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,066.19 to $1,067.08, inclusive.

(9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,067.26 to $1,068.20, inclusive.

(10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,068.27 to $1,069.17, inclusive.

(11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,069.81 to $1,070.64, inclusive.

(12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,070.96 to $1,071.75, inclusive.

(13) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,071.98 to $1,072.93, inclusive.

(14) The stock option fully vested in three years, where 1/3 vested on April 1, 2020, 1/3 vested on April 1, 2021, and the remainder vested on April 1, 2022.

**Signature:** /s/ Cherita Thomas, by POA from Deidra C. Merriwether, Sr. VP & CFO  
**Date:** 2026-03-25

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**